Maravai Lifesciences Holdings Inc Cl A (MRVI) Stock Price, Quote & News

Company Profile

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleosid...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 546 0004

Website: www.maravai.com

Address:

10770 Wateridge Circle, Suite 200, San Diego, United States

Iightning Nov. 22 at 12:06 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Sly15 Nov. 21 at 10:03 PM

$MRVI i like how this CEO rolls

0 · Reply

Sly15 Nov. 21 at 5:54 PM

$MRVI This one is going to go. The CEO is going to make it happen here. $7 is right around the corner, and I think this can be $15 in 12 months.

1 · Reply

Iightning Nov. 21 at 3:26 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 20 at 12:51 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 9:03 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

johnkimble Nov. 18 at 12:17 PM

$MRVI with all of the shares being bought by the CEO it’s also an easy buy below $4

0 · Reply

CEOBuysDisclosures Nov. 17 at 11:50 PM

$MRVI CEO purchased 216,212 shares at $3.25 for a total of $702,689. Brust Bernd now owns 2,466,771 shares. https://ceo-buys.com

0 · Reply

CEOBuysDisclosures Nov. 14 at 12:30 AM

$MRVI CEO purchased 250,559 shares at $3.23 for a total of $809,010. Brust Bernd now owns 2,250,559 shares. https://ceo-buys.com

0 · Reply

SuperGreenToday Nov. 12 at 5:22 AM

$MRVI Share Price: $3.26 Contract Selected: Mar 20, 2026 $1.5 Calls Buy Zone: $1.02 – $1.26 Target Zone: $1.77 – $2.16 Potential Upside: 64% ROI Time to Expiration: 128 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

Maravai LifeSciences Announces November 2025 Investor Conference Schedule

Nov 6, 2025, 11:26 PM EST - 15 days ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:01 PM EST - 15 days ago

Maravai LifeSciences Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 7:52 AM EDT - 24 days ago

MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders

Oct 22, 2025, 4:01 PM EDT - 4 weeks ago

Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025

Aug 11, 2025, 11:36 PM EDT - 3 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript

Aug 11, 2025, 4:05 PM EDT - 3 months ago

Maravai LifeSciences Reports Second Quarter 2025 Financial Results

Jul 28, 2025, 5:08 PM EDT - 4 months ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025

Jul 2, 2025, 8:49 AM EDT - 5 months ago

Johnson Fistel, PLLP Investigates Quantum Computing, AppLovin, Skyworks Solutions, and Maravai LifeSciences

APP QUBT SWKS

Jun 25, 2025, 4:01 PM EDT - 5 months ago

Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer

Jun 17, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation

Jun 15, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation

Jun 12, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Reach Out

Jun 10, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Reach Out

Jun 8, 2025, 10:00 AM EDT - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Connect

Jun 5, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Shareholders to Reach Out

Jun 3, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation

Jun 1, 2025, 10:00 AM EDT - 6 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

May 29, 2025, 10:05 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation

May 27, 2025, 10:00 AM EDT - 6 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

May 25, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Investors to Connect

May 22, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation

May 21, 2025, 4:22 PM EDT - 6 months ago

CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 6 months ago

Maravai LifeSciencesReleases 2024 Sustainability Report

May 21, 2025, 4:05 PM EDT - 6 months ago

Maravai LifeSciences Releases 2024 Sustainability Report

May 20, 2025, 8:00 AM EDT - 6 months ago

TriLink BioTechnologies® debuts its first mRNA synthesis kit with CleanCap® capping technology; Celebrates launch with kit donations to top academic institutions

May 18, 2025, 10:00 AM EDT - 6 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Maravai LifeSciences Holdings, Inc. (MRVI) And Encourages Stockholders to Connect

May 15, 2025, 10:00 AM EDT - 6 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

May 13, 2025, 1:29 PM EDT - 6 months ago

These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results

May 13, 2025, 12:03 AM EDT - 6 months ago

Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:06 PM EDT - 6 months ago

Maravai Lifesciences Reports First Quarter 2025 Financial Results

May 5, 2025, 5:47 AM EDT - 7 months ago

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - MRVI

May 1, 2025, 7:30 AM EDT - 7 months ago

Maravai LifeSciences To Host Earnings Conference Call on Monday, May 12, 2025

Apr 19, 2025, 7:36 AM EDT - 7 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences

Iightning Nov. 22 at 12:06 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Sly15 Nov. 21 at 10:03 PM

$MRVI i like how this CEO rolls

0 · Reply

Sly15 Nov. 21 at 5:54 PM

$MRVI This one is going to go. The CEO is going to make it happen here. $7 is right around the corner, and I think this can be $15 in 12 months.

1 · Reply

Iightning Nov. 21 at 3:26 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 20 at 12:51 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

Iightning Nov. 19 at 9:03 AM

1ightning® Options Trade Alert (Actionable) | Buy $MRVI Dec 19 $5 Call | Enter: $0.17 Exit: $0.32 | Profit: 84.01% ROI | https://1ightning.com

0 · Reply

johnkimble Nov. 18 at 12:17 PM

$MRVI with all of the shares being bought by the CEO it’s also an easy buy below $4

0 · Reply

CEOBuysDisclosures Nov. 17 at 11:50 PM

$MRVI CEO purchased 216,212 shares at $3.25 for a total of $702,689. Brust Bernd now owns 2,466,771 shares. https://ceo-buys.com

0 · Reply

CEOBuysDisclosures Nov. 14 at 12:30 AM

$MRVI CEO purchased 250,559 shares at $3.23 for a total of $809,010. Brust Bernd now owns 2,250,559 shares. https://ceo-buys.com

0 · Reply

SuperGreenToday Nov. 12 at 5:22 AM

0 · Reply

ASTANA Nov. 9 at 9:07 AM

https://endpoints.news/zuckerberg-backed-biohub-hires-evolutionaryscale-team-in-apparent-end-of-ai-startup/ $MRVI

0 · Reply

johnkimble Nov. 5 at 5:47 AM

$MRVI easy buy below $3

0 · Reply

painkiller07 Nov. 4 at 1:02 PM

$MRVI this pos was trading at 45 when i sold it. They had a chance to sold the company at 40 dollars. what a farce.

0 · Reply

SqueezeChronometer Nov. 2 at 11:26 AM

Next major retail squeeze candidate right here $EFTY $VNTG $GTI $MRVI 7

0 · Reply

MSUalum Oct. 16 at 9:34 PM

$MRVI maybe gtcr finally got repligen back to the table? This has been trading unusually strong.

1 · Reply

Theflash88 Oct. 11 at 1:38 PM

$MRVI It will hit $8 before $4.

1 · Reply

Theflash88 Oct. 11 at 1:37 PM

$MRVI Back in.. I predict a buyout before EOY. Mark this post. Not hype.. but my opinion.

1 · Reply

xtrmntr Oct. 11 at 3:00 AM

$MRVI Held up well today, relatively speaking. Must have some high conviction holders, finally.

0 · Reply

Nolanmp26 Oct. 9 at 4:03 PM

$MRVI False wall put up at $3.40. Slap that ask and see what happens!

0 · Reply

Nolanmp26 Oct. 9 at 12:43 PM

$MRVI Smash the ask and break $3.40 and we will have something…

0 · Reply

johnkimble Oct. 6 at 4:59 AM

$MRVI how many days until this hits $4?

1 · Reply

SignalStalker Oct. 5 at 12:33 PM

$MRVI Healthcare technology. Testing key support. Volume pattern shows distribution. Growth concerns persisting.

0 · Reply

Market Cap	874.52M
Revenue (ttm)	259.19M
Net Income (ttm)	-144.85M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-55.89%
Debt to Equity Ratio	0.68

Volume	2,459,700
Avg Vol	1,612,824
Day's Range	N/A - N/A
Shares Out	255.71M
Stochastic %K	94%
Beta	0.34
Analysts	Sell
Price Target	$4.19